MENU
PJP
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

PJP stock forecast, quote, news & analysis

The investment seeks to track the investment results (before fees and expenses) of the Dynamic Pharmaceutical IntellidexSM Index... Show more

Category: #Health
PJP
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for PJP with price predictions
Sep 18, 2026

PJP's Indicator enters downward trend

The Aroon Indicator for PJP entered a downward trend on September 18, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 143 similar instances where the Aroon Indicator formed such a pattern. In 111 of the 143 cases the stock moved lower. This puts the odds of a downward move at 78%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for PJP moved out of overbought territory on August 26, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 36 similar instances where the indicator moved out of overbought territory. In 27 of the 36 cases, the stock moved lower in the following days. This puts the odds of a move lower at 75%.

The Momentum Indicator moved below the 0 level on September 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PJP as a result. In 62 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 70%.

The Moving Average Convergence Divergence Histogram (MACD) for PJP turned negative on August 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 29 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 63%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PJP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

PJP moved above its 50-day moving average on September 16, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +1.75% 3-day Advance, the price is estimated to grow further. Considering data from situations where PJP advanced for three days, in 265 of 322 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

PJP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), Regeneron Pharmaceuticals (NASDAQ:REGN).

Industry description

The investment seeks to track the investment results (before fees and expenses) of the Dynamic Pharmaceutical IntellidexSM Index. The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of 30 U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.

Market Cap

The average market capitalization across the Invesco Pharmaceuticals ETF (PJP) ETF is 118.49B. The market cap for tickers in the group ranges from 741.29M to 1.03T. LLY holds the highest valuation in this group at 1.03T. The lowest valued company is COLL at 741.29M.

High and low price notable news

The average weekly price growth across all stocks in the Invesco Pharmaceuticals ETF (PJP) ETF was 1%. For the same ETF, the average monthly price growth was -5%, and the average quarterly price growth was 26%. AMRX experienced the highest price growth at 10%, while TVTX experienced the biggest fall at -5%.

Volume

The average weekly volume growth across all stocks in the Invesco Pharmaceuticals ETF (PJP) ETF was 233%. For the same stocks of the ETF, the average monthly volume growth was 81% and the average quarterly volume growth was -33%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 49
Price Growth Rating: 43
SMR Rating: 61
Profit Risk Rating: 52
Seasonality Score: -11 (-100 ... +100)
View a ticker or compare two or three
PJP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Details
Category
Health
Address
Powershares Exchange Traded Fund Trust227 E Prairie AveWheaton
Phone
N/A
Web
www.invescopowershares.com